Staphylococcus antigen and vaccine

Details Staphylococcus antigen and vaccine Staphylococcus antigen and vaccine

2005-08-30

2005-08-30

Minnifield, Nita (Department: 1645)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Bacterium or component thereof or substance produced by said...

C424S278100, C424S234100, C424S184100, C424S237100, C424S235100, C424S197110, C530S300000, C530S350000, C530S866000, C530S387100, C435S069300, C435S007330, C514S002600

Reexamination Certificate

active

06936258

ABSTRACT:
A negatively-chargedStaphylococcusantigen contains amino acids and a N-acetylated hexosamine as a major carbohydrate component. The antigen is common to many coagulase-negative strains ofStaphylococcus, includingS. epidermidis, S. haemolyticus, andS. hominis. Staphylococcusstrains that carry the antigen include many clinically significant strains ofStaphylococcus. The antigen and antibodies to the antigen are useful in kits and assays for diagnosingStaphylococcusinfection. Vaccines of the antigen and of whole cells that carry the antigen also are disclosed.

REFERENCES:
patent: 4902616 (1990-02-01), Fournier et al.
patent: 5770208 (1998-06-01), Fattom et al.
patent: 5961975 (1999-10-01), Fattom et al.
patent: 6045805 (2000-04-01), Moreau
patent: 6194161 (2001-02-01), Fattom et al.
patent: 6294177 (2001-09-01), Fattom
patent: 6355625 (2002-03-01), Pavliak et al.
patent: 6537559 (2003-03-01), Fattom
patent: 2002/0031528 (2002-03-01), Fattom
patent: 2003/0113350 (2003-06-01), Fattom et al.
patent: 93/09811 (1993-05-01), None
patent: 98/10788 (1998-03-01), None
patent: 98/28002 (1998-07-01), None
patent: WO 00/56357 (2000-09-01), None
Fattom et al, Vaccine, 13/14:1288-1293, 1995.
Fattom et al, Infection & Immunity 64/5:1659-1665, 1996.
Lee et al, Infection & Immunity, 65/10:4146-4150, 1997.
Shinefield et al NEJM. 346/7:491-496 Abstract Only, 2002.
Fattom et al, Infection & Immunity, 61/3:1023-32, 1993.
Fattom et al, Infection & Immunity 60/2:584-89, 1992.
Karakawa et al, J. Exp. Med. 128/2:325-340, 1968.
Osawa et al., Biochemistry, 8/8: 3369-3375, 1969.
Kusumoto et al, Bull. Chem. Soc. Jpn. 49/2: 533-539, 1976.
Fattom et al, Infection & Immunity 66/10:4588-4592, 1998.
Gunnarsson et al, Infection & Immunity 45/1:41-46, 1984.
Ohshima Y., “Cell Surface Antigen of EncapsulatedStaphylococcus-epidermidisSE-360 Protects Mice From Homologous Infection”, Zbl. Bakt. Hyg. Series A vol. 270, pp. 219-227, (1988) XP000939097.
Kojima et al, “Antibody to the Capsular Polysaccharide/Adhesion Protects Rabbits against Catheter-related Bateremia due to Coagulase-Negative Staphylococci”, J. of Infec. Diseases, vol. 162, pp. 435-441 (1990) XP000867597.
Tojo et al.; “Isolation and Characterization of a Capsular Polysaccharide Adhesion FromStaphylococcus epidermidis”; The Journal of Infectious Diseases; vol. 157, No. 4; Apr. 1988; pp. 713-722.
Timmerman et al.; “Characterization of a Proteinaceous Adhesion ofStaphylococcus epidermidisWhich Mediates Attachment to Polystyrene”; Infection and Immunity; vol. 59, No. 11; Nov. 1991; pp. 4187-4192.
Mack et al.; Characterization of Transposon Mutants of Biofilm-ProducingStaphylococcus epidermidisImpaired in the Accumulative Phase of Biofilm Production: Genetic Identification of a Hexosamine-Containing Polysaccharide Intercellular Adhesin; Infection and Immunity; vol. 62, No. 8; Aug. 1994; pp. 3244-3253.
Mack et al.; “Parallel Induction by Glucose of Adherence and a Polysaccharide Antigen Specific for Plastic-AdherentStaphylococcus epidermidis: Evidence for Functional Relation to Intercellular Adhesion”; Infection and Immunity; vol. 60, No. 5; May 1992; pp. 2048-2057.
Mack et al.; “The Intercellular Adhesion Involved in Biofilm Accumulation ofStaphylococcus epidermidisIs A Linear β-1,6-Linked Glucosaminoglycan: Purification and Structural Analysis”; Bacteriology: vol. 178, No. 1; Jan. 1996; pp. 175-183.
Hussain et al.; “A 140-Kilodalton Extracellular Protein is Essential for the Accumulation ofStaphylococcus epidermidisStrains on Surfaces;”; Infection and Immunity; vol. 65, No. 2; Feb. 19997; pp. 519-524.

Affiliated with

Also associated with

Rating

Staphylococcus antigen and vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Staphylococcus antigen and vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Staphylococcus antigen and vaccine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3471342